A commercial-stage biopharmaceutical company focused on therapies for pain management and oncology supportive care. Its portfolio includes non‑opioid postoperative pain treatments and anti-nausea medicines used alongside cancer therapy, with revenue tied to hospital adoption and drug utilization. In...
1 member of Congress has disclosed 1 trade in Heron Therapeutics, Inc. (HRTX), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2021-03-31 | Ashley Hinson Arenholz | sell | $1K – $15K |